Why did the U.S. FDA decline to review the new mRNA influenza vaccine?

The FDA declined to review Moderna's mRNA influenza vaccine due to inadequate clinical trial comparators for older adults.
New Atlas

mRNA flu shot far more effective than current vaccine – but there are issues

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...
STAT

Kennedy’s case against mRNA vaccines collapses under his own evidence

When Health and Human Services Secretary Robert F. Kennedy Jr. terminated $500 million in federal funding for mRNA vaccine research last week, claiming he had “reviewed the science,” his press release ...
Hosted on MSN

Cancer vaccines: Shot in the arm to prevent the deadly disease?

Cancer continues to be one of the deadliest non-communicable diseases in the world. Every year, the number of cases rises drastically even as medical care races to develop newer and more effective ...

Moderna’s dual Covid-flu vaccine poised for EMA approval on positive CHMP take

If approved, mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across the globe ...